查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771670

美國無菌連接器和焊接機市場規模、佔有率、趨勢分析報告（按產品、應用、最終用途、細分市場預測，2025 年至 2033 年）

U.S. Aseptic Connectors And Welders Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國無菌連接器和焊接機市場的成長和趨勢：

根據Grand View Research, Inc.的最新報告，預計到2033年，美國無菌連接器和焊接器市場規模將達到23.5億美元，2025年至2033年的複合年成長率為14.8%。隨著生物製藥製造業對無菌封閉式系統解決方案的需求不斷成長，該市場正經歷強勁成長。一次性技術的興起，加上生技藥品、疫苗、細胞和基因療法產品線的不斷拓展，正在推動先進無菌流體處理系統的應用。製造商將污染預防、營運靈活性和法規合規性放在首位。

模組化和靈活生產設施的日益普及，進一步推動了市場發展，尤其是在合約研究組織 (CRO)、合約生產組織 (CMO) 和新興生物技術公司中。隨著縮短開發週期和降低污染風險的壓力日益增大，各公司正在投資於能夠適應不同批次規模和製程需求的堅固耐用、隨時可用的無菌系統。

連接器設計、自動化管焊機以及與智慧製造平台整合的技術進步提高了生產效率，減少了人為錯誤，並支援即時製程監控。這些創新使無菌流體能夠跨各種上游和下游處理步驟進行傳輸，從細胞培養和培養基製備到最終填充完成。隨著無菌處理標準日益嚴格，對經過驗證、符合 GMP 要求且可擴展的流體處理解決方案的需求正在重塑藥物開發商和契約製造的籌資策略。

隨著技術創新不斷重塑生物製造，美國無菌連接器和焊接機市場有望在實現下一代無菌、高效且可擴展的藥物製造方面發揮關鍵作用。隨著策略夥伴關係關係、產品擴展和數位化整合的日益成長，該市場有望支持全球生物製藥和先進療法製造的未來成長。

美國無菌連接器和焊接機市場報告重點

  • 從產品來看，2024年，無菌連接器佔據了美國無菌連接器和焊接器市場的主導地位。這種主導地位歸因於其在一次性生物製程系統中的廣泛應用，在這些系統中，保持無菌和封閉的流體路徑至關重要。與傳統方法相比，無菌連接器具有更高的靈活性、易用性並降低了污染風險，使其成為需要頻繁更換和模組化系統配置的製程的理想選擇。
  • 從應用角度來看，上游生物加工將在2024年以44.99%的市場佔有率引領市場，佔據最大的收入佔有率。該領域佔據主導地位，是因為在培養基製備、細胞培養和發酵過程中保持無菌至關重要。無菌連接器和焊接機支援每個階段無菌液體的處理，最大限度地降低風險並確保穩定的產量。隨著mRNA療法、單株抗體和先進生技藥品的興起，上游生物加工將繼續成為無菌技術投資和創新的重點。
  • 根據最終用途， OEM（目的地設備製造商）細分市場在2024年佔據了最大的市場佔有率，達到46.20%。 OEM已成為將無菌連接器和焊接器整合到經濟高效的生物處理設備和一次性系統中的重要參與者，為生物製藥製造商提供檢驗的即用型解決方案。 OEM與藥品開發商和契約製造製造商建立了牢固的夥伴關係關係，這進一步鞏固了OEM的主導地位，這些開發商和合約製造商依靠OEM提供預先配置的匹配系統來簡化營運。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國無菌連接器和焊接機市場變數和趨勢

  • 市場展望
    • 母市場展望
    • 相關/輔助市場展望。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 無菌連接器和焊接器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章美國無菌連接器和焊接機市場：產品評估和趨勢分析

  • 產品細分儀表板
  • 美國無菌連接器和焊接器市場產品差異分析
  • 2021 年至 2033 年美國無菌連接器及焊接機市場規模及趨勢分析（依產品）
  • 無菌連接器
    • 連接類型
    • 管尺寸
  • 無菌焊接機

第5章美國無菌連接器和焊接機市場：應用評估和趨勢分析

  • 應用程式細分儀表板
  • 美國無菌連接器及焊接器市場應用趨勢分析
  • 美國無菌連接器及焊接機市場規模及應用趨勢分析（2021-2033）
    • 上游生物加工
    • 其他用途
    • 下游生物加工
    • 收穫和育肥

第6章美國無菌連接器和焊接機市場：最終用途估計和趨勢分析

  • 最終用途細分儀表板
  • 美國無菌連接器和焊接器市場最終用途變化分析
  • 美國無菌連接器和焊接機市場規模及趨勢分析（依最終用途），2021 年至 2033 年
  • 生物製藥和製藥公司
  • OEM
  • CRO 和 CMO
  • 學術研究所

第7章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Sartorius AG
    • Merck KGaA
    • Danaher Corporation（Cytiva）
    • Saint-Gobain
    • Dover Corporation（Colder Products Company）
    • Liquidyne Process Technologies, Inc.
    • MGA Technologies
    • Watson-Marlow Fluid Technology Solutions
    • Terumo BCT, Inc.
    • LePure Biotech LLC
Product Code: GVR-4-68040-629-4

U.S. Aseptic Connectors And Welders Market Growth & Trends:

The U.S. aseptic connectors and welders market size is projected to reach USD 2.35 billion by 2033, growing at a CAGR of 14.8% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is experiencing strong growth, driven by the increasing demand for sterile, closed-system solutions in biopharmaceutical manufacturing. The rise of single-use technologies, combined with the expanding pipeline of biologics, vaccines, cell, and gene therapies are fueling the adoption of advanced aseptic fluid handling systems. Manufacturers prioritize contamination control, operational flexibility, and regulatory compliance.

The growing adoption of modular, flexible manufacturing facilities further reinforces the market's momentum, especially among CROs, CMOs, and emerging biotech firms. With increasing pressure to shorten development timelines and reduce contamination risks, companies invest in robust, ready-to-deploy aseptic systems that adapt to different batch sizes and process needs.

Technological advancements in connector design, automated tube welders, and integration with smart manufacturing platforms improve production efficiency, reduce human error, and support real-time process monitoring. These innovations enable sterile fluid transfer across various upstream and downstream processing stages, from cell culture and media preparation to final fill-finish. As aseptic processing standards tighten, the need for validated, GMP-compliant, and scalable fluid handling solutions reshape procurement strategies among drug developers and contract manufacturers.

As innovation continues to reshape the biomanufacturing landscape, the U.S. aseptic connectors and welders market is poised to play a critical role in enabling the next generation of sterile, efficient, and scalable drug production. With strategic partnerships, product expansion, and digital integration on the rise, the market is well-positioned to support future growth in global biopharma and advanced therapeutic production.

U.S. Aseptic Connectors And Welders Market Report Highlights:

  • By product, aseptic connectors dominated the U.S. aseptic connectors and welders market in 2024. This dominance is attributed to their widespread use in single-use bioprocessing systems, where maintaining sterile, closed fluid pathways is critical. Aseptic connectors offer greater flexibility, ease of use, and reduced risk of contamination compared to traditional methods, making them ideal for processes that require frequent changeovers or modular system configurations.
  • By application, upstream bioprocessing led the market with a share of 44.99% in 2024, accounting for the largest revenue share. This segment's dominance is driven by the critical need to maintain sterility during media preparation, cell culture, and fermentation processes, where contamination can compromise entire production runs. Aseptic connectors and welders support sterile fluid handling at each stage, minimizing risk and ensuring consistent yields. With the rise of mRNA therapies, monoclonal antibodies, and advanced biologics, upstream bioprocessing remains a primary focus for investment and innovation in aseptic technologies.
  • By end use, OEMs (Original Equipment Manufacturers) segment held the largest market share of 46.20% in 2024. OEMs integrate aseptic connectors and welders into cost-effective bioprocessing equipment and single-use systems, making them essential players in delivering validated, ready-to-use solutions to biopharmaceutical manufacturers. Their dominance is reinforced by strong partnerships with drug developers and contract manufacturers, who rely on OEMs for pre-configured, compliant systems that streamline operations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Aseptic Connectors and Welders Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Expansion of Vaccine and Therapeutic Production
      • 3.2.1.2. Rise in the Adoption of Single-Use Technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Manufacturing Costs
      • 3.2.2.2. Regulatory Compliance
  • 3.3. Aseptic Connectors and Welders Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Aseptic Connectors and Welders Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Aseptic Connectors and Welders Market Product Movement Analysis
  • 4.3. U.S. Aseptic Connectors and Welders Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Aseptic Connectors
    • 4.4.1. Aseptic Connectors market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Connection type
      • 4.4.2.1. Connection type market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.2. Barbed fittings
      • 4.4.2.3. Barbed fittings market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.4. Luer locks
      • 4.4.2.5. Luer locks market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.6. Genderless
      • 4.4.2.7. Genderless market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.2.8. Others
      • 4.4.2.9. Others market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Tubing Size
      • 4.4.3.1. Tubing Size market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.2. 1/16 Inch
      • 4.4.3.3. 1/16 Inch-triphosphate market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.4. 1/4 Inch
      • 4.4.3.5. 1/4 Inch market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.6. 3/8 Inch
      • 4.4.3.7. 3/8 Inch market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.3.8. Others
      • 4.4.3.9. Others market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Aseptic Welders
    • 4.5.1. Aseptic Welders market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. U.S. Aseptic Connectors and Welders Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Aseptic Connectors and Welders Market Application Movement Analysis
  • 5.3. U.S. Aseptic Connectors and Welders Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 5.3.1. Upstream Bioprocessing
      • 5.3.1.1. Upstream Bioprocessing market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.2. Media Preparation
      • 5.3.1.3. Media Preparation market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.4. Cell Inoculation
      • 5.3.1.5. Cell Inoculation market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.6. Cell Expansion
      • 5.3.1.7. Cell Expansion market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.1.8. Sampling
      • 5.3.1.9. Sampling market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.3.2. Other applications
      • 5.3.2.1. Other applications market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.3.3. Downstream Bioprocessing
      • 5.3.3.1. Downstream Bioprocessing market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.2. Purification
      • 5.3.3.3. Purification market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.4. Filtration
      • 5.3.3.5. Filtration market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.6. Sampling
      • 5.3.3.7. Sampling market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.8. Fluid Transfer
      • 5.3.3.9. Fluid Transfer market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.3.10. Other Applications
      • 5.3.3.11. Other Applications market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.3.4. Harvest & Fill-finish Operations
      • 5.3.4.1. Harvest & Fill-finish Operations market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.2. Product Collection
      • 5.3.4.3. Product Collection market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.4. Filtration
      • 5.3.4.5. Filtration market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.6. Product Filling
      • 5.3.4.7. Product Filling market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.8. Sampling
      • 5.3.4.9. Sampling market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.3.4.10. QC Testing
      • 5.3.4.11. QC Testing market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. U.S. Aseptic Connectors and Welders Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. Aseptic Connectors and Welders Market End Use Movement Analysis
  • 6.3. U.S. Aseptic Connectors and Welders Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. OEMs
    • 6.5.1. OEMs market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. CROs & CMOs
    • 6.6.1. CROs & CMOs market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Academic & Research Institutes
    • 6.7.1. Academic & research institutes market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Danaher Corporation (Cytiva)
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Saint-Gobain
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Dover Corporation (Colder Products Company)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Liquidyne Process Technologies, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. MGA Technologies
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.4. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Watson-Marlow Fluid Technology Solutions
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Terumo BCT, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. LePure Biotech LLC
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 U.S. Aseptic connectors and welders Market, By product, 2021 - 2033 (USD Million)
  • Table 5 U.S. Aseptic connectors and welders Market, By application, 2021 - 2033 (USD Million)
  • Table 6 U.S. Aseptic connectors and welders Market, By end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Aseptic connectors and welderss market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Aseptic connectors & welders market: Product outlook key takeaways
  • Fig. 13 Aseptic connectors & welders market: Product movement analysis
  • Fig. 14 U.S. aseptic connectors market, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. aseptic welders market, 2021 - 2033 (USD Million)
  • Fig. 16 Aseptic connectors & welders market: Application outlook and key takeaways
  • Fig. 17 Aseptic connectors & welders market: Application movement analysis
  • Fig. 18 U.S. upstream bioprocessing market, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. downstream bioprocessing market, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. harvest & fill-finish operations market, 2021 - 2033 (USD Million)
  • Fig. 21 Aseptic connectors & welders market: End use outlook and key takeaways
  • Fig. 22 Aseptic connectors & welders market: End use movement analysis
  • Fig. 23 U.S. biopharmaceutical & pharmaceutical companies market, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. OEMs market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. CROs & CMOs market, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. academic & research institutes market, 2021 - 2033 (USD Million)